BRPI0815597A2 - Formulações de emulsões com derivado de pirazolona - Google Patents

Formulações de emulsões com derivado de pirazolona

Info

Publication number
BRPI0815597A2
BRPI0815597A2 BRPI0815597-6A2A BRPI0815597A BRPI0815597A2 BR PI0815597 A2 BRPI0815597 A2 BR PI0815597A2 BR PI0815597 A BRPI0815597 A BR PI0815597A BR PI0815597 A2 BRPI0815597 A2 BR PI0815597A2
Authority
BR
Brazil
Prior art keywords
pirazolona
formulations
emulsions
derivative
derivative emulsions
Prior art date
Application number
BRPI0815597-6A2A
Other languages
English (en)
Inventor
Kiichiro Nabeta
Original Assignee
Teikoku Pharma Usa Inc
Techno Guard Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc, Techno Guard Co Ltd filed Critical Teikoku Pharma Usa Inc
Publication of BRPI0815597A2 publication Critical patent/BRPI0815597A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI0815597-6A2A 2007-11-21 2008-11-07 Formulações de emulsões com derivado de pirazolona BRPI0815597A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98970707P 2007-11-21 2007-11-21
PCT/US2008/082842 WO2009067343A1 (en) 2007-11-21 2008-11-07 Pyrazolone derivative emulsion formulations

Publications (1)

Publication Number Publication Date
BRPI0815597A2 true BRPI0815597A2 (pt) 2014-09-30

Family

ID=40642635

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815597-6A2A BRPI0815597A2 (pt) 2007-11-21 2008-11-07 Formulações de emulsões com derivado de pirazolona

Country Status (13)

Country Link
US (1) US8168670B2 (pt)
EP (1) EP2230912A4 (pt)
JP (1) JP5509090B2 (pt)
KR (2) KR101235085B1 (pt)
CN (1) CN101801195A (pt)
AR (1) AR069386A1 (pt)
AU (1) AU2008326593B2 (pt)
BR (1) BRPI0815597A2 (pt)
CA (1) CA2695605C (pt)
EA (1) EA018458B1 (pt)
TW (1) TWI376240B (pt)
WO (1) WO2009067343A1 (pt)
ZA (1) ZA201000780B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101966149B (zh) * 2010-09-25 2012-02-15 西安力邦制药有限公司 一种脑梗塞治疗药物脂肪乳剂的制备
US8747534B2 (en) * 2010-12-29 2014-06-10 United States Gypsum Company Antimicrobial size emulsion and gypsum panel made therewith
CN102058531B (zh) * 2011-01-11 2012-09-19 西安力邦制药有限公司 一种脑保护治疗药物脂肪乳剂的制备
CN113768879A (zh) 2016-03-16 2021-12-10 苏州澳宗生物科技有限公司 依达拉奉剂型
PL3551181T3 (pl) * 2017-01-17 2021-05-31 Treeway Tw001 B.V. Leczenie obejmujące doustne lub dożołądkowe podawanie edarawonu
CN109431966B (zh) * 2018-04-27 2020-09-22 首都医科大学附属北京天坛医院 依达拉奉药物组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
JPS5931689B2 (ja) * 1978-01-23 1984-08-03 富士写真フイルム株式会社 油溶性写真用添加剤の分散方法
US4360518A (en) * 1979-08-06 1982-11-23 Johnson & Johnson Topical anti-inflammatory drug therapy
DE3308881A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Verwendung von pyrazolonderivaten als lipoxygenasehemmer, bei der therapie von ischaemien und herzrhythmusstoerungen sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung
DE3312581A1 (de) * 1983-04-08 1984-10-11 Bayer Ag, 5090 Leverkusen Verwendung von pyrazolonderivaten bei der bekaempfung des wachstums von tumorzellen und der metastasenbildung, arzneimittel hierfuer und verfahren zu deren herstellung
US6455525B1 (en) * 1999-11-04 2002-09-24 Cephalon, Inc. Heterocyclic substituted pyrazolones
US20030109566A1 (en) * 2000-06-29 2003-06-12 Tomiya Mano Remedial agent for optic nerve disease and the like
KR100921199B1 (ko) * 2001-05-11 2009-10-13 미쓰비시 타나베 파마 코퍼레이션 안정하고 고농도인 피라졸론 유도체를 포함하는 주사제
KR20050114606A (ko) * 2003-01-10 2005-12-06 미츠비시 웰파마 가부시키가이샤 혈액뇌관문 파탄 억제제
CN1440749A (zh) * 2003-03-24 2003-09-10 南昌弘益科技有限公司 易达拉封注射剂及其制备工艺——治疗急性脑梗塞
DE102004025357B4 (de) * 2004-05-19 2007-03-29 Beiersdorf Ag Emulsionskonzentrat mit wasserlöslichen und öllöslichen Polymeren und kosmetische Zubereitung enthaltend Emulsionskonzentrat sowie ein Verfahren zu dessen Herstellung und dessen Verwendung
JP4746856B2 (ja) * 2004-08-12 2011-08-10 三笠製薬株式会社 ピラゾロン系製剤
US20070116769A1 (en) * 2004-11-01 2007-05-24 Novozymes A/S Continuous encapsulation process
US20060189682A1 (en) * 2005-02-02 2006-08-24 Payne Joseph E Water soluble prodrugs of COX-2 inhibitors
JP2006298774A (ja) * 2005-04-15 2006-11-02 Lead Chemical Co Ltd 経皮吸収型フリーラジカル抑制製剤
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby

Also Published As

Publication number Publication date
WO2009067343A1 (en) 2009-05-28
KR20100091939A (ko) 2010-08-19
TW200936181A (en) 2009-09-01
EP2230912A4 (en) 2013-05-01
JP2011504177A (ja) 2011-02-03
KR20120125403A (ko) 2012-11-14
EA018458B1 (ru) 2013-08-30
CA2695605C (en) 2013-04-09
CN101801195A (zh) 2010-08-11
EA201000266A1 (ru) 2010-10-29
AU2008326593A1 (en) 2009-05-28
AU2008326593B2 (en) 2013-09-05
US8168670B2 (en) 2012-05-01
KR101235085B1 (ko) 2013-02-20
US20090131496A1 (en) 2009-05-21
TWI376240B (en) 2012-11-11
CA2695605A1 (en) 2009-05-28
ZA201000780B (en) 2011-04-28
JP5509090B2 (ja) 2014-06-04
EP2230912A1 (en) 2010-09-29
AR069386A1 (es) 2010-01-20

Similar Documents

Publication Publication Date Title
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
PT2170388T (pt) Formulações de anticorpos anti-cd20
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
EP2167043A4 (en) NEW USE CO-CRYSTAL COMPOSITIONS
EP2226315A4 (en) 2-aminoquinazoline DERIVATIVE
BRPI0814805A2 (pt) Emulsões duplas estáveis
LT2966175T (lt) Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
EP2194045A4 (en) Substituted pyrazole derivative
EP2120573A4 (en) piperidine
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
EP2124523A4 (en) BREEDING LINE P2428-5006090
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0818079A2 (pt) composição de lipideo
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0814188A2 (pt) Formulações
CR10562A (es) Nuevos derivados de piridazina
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0722002A2 (pt) composições de desodorante
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
BRPI0921947A2 (pt) formulações de proteína terapêutica
EP2110789A4 (en) PAPER MONEY PROCESSOR
BRPI0817442A2 (pt) Formulações galênicas de composto orgânicos
BRPI0917210A2 (pt) exoterma controlada de formulações de cianocrilato
BRPI0820198A2 (pt) composições farmacêuticas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.